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Progress Report Summary 
1. Specific Aims 
The central hypothesis underlying this project is that sickle 
erythrocytes contribute to arterial lesions by altering 
endothelial and smooth muscle cell structure and function and that 
/ 
endothelial alterations induced by sickle erythrocytes are 
modulated by the hemodynamic environment. Within this hypothesis, 
the overall goal is to characterize in vitro the alterations in 
endothelial cell structure and function due to contact with sickle 
erythrocytes, including the mechanisms involved. 
The specific aims thus are as follows: (i} characterize 
changes in endothelial cell morphology, F-actin localization, and 
extracellular matrix composition due to interactions with sickle 
erythrocytes; (ii} determine the effect of sickle erythrocytes on 
endothelial cell proliferation; and (iii} quantify endothelial 
cell synthesis and secretion of biologically active molecules, 
e.g. vasoactive substances (NO, ET-1}, growth factors (FGF, PDGF), 
and thrombotic markers (PGI
2
, tissue factor}, and expression of 
cell adhesion molecules (VCAM-1, ICAM-1, E-Selectin} as induced by 
sickle erythrocytes. These studies are to be performed under 
physiological flow conditions in order to elucidate the complex 
interactions between erythrocytes, endothelial cells and 
hemodynamics which may take place in lesion-prone vessels in vivo. 
To date we have made significant progress on the first two of 
these specific aims, and the results obtained are described in the 
next section. We also have conducted some studies related to 
specific aim (iii). These were described in the progress report 
submitted January 1994. 
2. Studies and Results 
Vascular endothelial cells exhibit what may be called an 
elongation response, i.e. they are elongated and aligned in the 
presence of flow, with the alignment being in the direction of 
flow. This has been observed both in vivo and in vitro. If 
sickle erythrocytes in any way are injurious to endothelium, then 
there may be an influence of this ''injury" on the endothelial cell 
elongation response. It is thus our hypothesis that sickle 
erythrocytes inhibit the normal elongation and alignment response 
of endothelial cells subjected to flow and the associated shear 
stress. 
To test this hypothesis, confluent monolayers of bovine 
aortic endothelial cells (BAEC) have been statically preincubated 
with cell culture medium, washed normal red blood cells (NRBC), or 
washed sickle red blood cells (SRBC) for 5 minutes and then 
exposed to cell culture medium at a steady laminar shear stress of 
30 dynes/cm 2 for up to 36 hours. The shape index (SI) of 
endothelial cells has been used as a measure of endothelial 
elongation, with a SI of 1 indicating rounded cells, circular in 
shape, and a SI of 0 indicating the limiting case of a straight 
line. The SI was determined for each condition and for up to 36 
hours after the onset of flow. The data obtained has been 
reported previously; however, it should be noted that in all 
experiments, endothelial viability was not less than 90% for up to 
3 6 hours after the onset of shear stress. The SI of BAEC 
preexposed to SRBC retained an essentially constant value, i.e. a 
circular shape, this through the duration of the experiment up to 
36 hours of exposure to flow and a 30 dynes/cm 2 shear stress. This 
is in marked contrast to BAEC preexposed to NRBC and exposed to 30 
dynes/cm2 shear stress where the SI decreased in a similar fashion 
to exposure to culture medium, indicating normal BAEC elongation. 
In fact, the SI time course of BAEC elongation after preexposure 
to culture medium was identical to that measured for BAEC 
preexposed to NRBC. Shear-induced BAEC elongation also was 
inhibited by preexposure to either NRBC or SRBC lysed by 
sonication. When BAEC were preexposed to sickle hemoglobin from 
lysed SRBC depleted of membrane fragments, inhibition of 
elongation in response to shear also was observed. This suggests 
that hemoglobin may be a primary contributor to the inhibition of 
endothelial elongation described above. Additional experiments 
indicate that BAEC, when preexposed to supernatant from washed, 
centrifuged SRBC, also exhibit an inhibition of elongation. 
Since the elongation of an endothelial cell depends on its 
ability to reorganize its actin microfilament structure, then an 
impairment of this elongation response might be expected to be 
associated with an alteration in the localization of F-actin. We 
thus also have investigated the localization of F-actin in 
endothelial cells using rhodamine phalloidin and fluorescent 
microscopy. Endothelial cells in static culture exhibit a dense 
peripheral band of F-actin. When subjected to flow, the F-actin 
in endothelial cells is reorganized into stress fibers aligned 
parallel to the direction of flow and thus the cell's major axis. 
However, if incubated first with washed SRBC, then when subjected 
to flow, little reorganization of the F-actin was observed to 
occur. 
A continuing objective has been to study the mechanism(s) 
that might be involved in the observed inhibition of the 
elongation response. It was not only treatment of endothelial 
mono layers with SRBC, but also treatment with suspensions of 
sonicated SRBC and NRBC which caused the observed inhibition of 
elongation. Thus, there is a suggestion that free hemoglobin, 
released into the media when the RBC membranes are disrupted, may 
be a potential elongation-inhibiting substance. This hypothesis 
is supported by the studies of Vercelotti and coworkers1 · 2 in which 
they examined the damaging effects of free heme on porcine aortic 
endothelial cells and found that it is toxic after only a one hour 
exposure. 
To study a possible role of free hemoglobin, the 
concentration of hemoglobin in RBC and sonicated RBC suspensions, 
similar to those used previously, was first assayed 
spectrophotometrically. For both cell types this was found to be 
in the range of 0.04-0.08 mg/mL and 6-7 mg/mL respectively. 
Experiments were then initiated, similar to the earlier ones, 
except RBC suspensions were replaced by Hb S and Hb A solutions. 
The initial concentrations of hemoglobin used were 6-7 mg/mL, 
similar to that assayed for the sonicated suspensions. The 
results of these experiments indicate that sickle hemoglobin 
causes a significant amount of endothelial denudation as compared 
to normal hemoglobin or DMEM control. Figure 1 is a plot of the 
change of shape index over time, comparing Hb S, Hb A, and DMEM 
control. In the Hb S experiments, the shape index represents the 
cells that did not shear off of the slide. These results indicate 
that while hemoglobin, at a concentration representative of the 
sonicated RBC samples, does have somewhat of an inhibitory effect, 
it is no where near as great as that previously observed. The 
denudation effect, however, is an important one which we would 
like to follow up. 
We believe that the SRBC effects on endothelial cells also 
will be reflected in ,endothelial cell function. To test this, a 
variety of studies have been initiated or are planned. For our 
studies on cell proliferation the protocol used was described in 
last year's progress report. The cell proliferation results 
obtained to date are presented in Figures 2-4. There really are 
two separate questions to be addressed. First, in static culture 
do endothelial cells preconditioned by contact with SRBC exhibit 
an altered rate of proliferation? Secondly, for an endothelial 
monolayer exposed to steady flow and the associated shear stress, 
does preconditioning with SRBC alter the effect of flow on the 
rate of proliferation? 
In regard to the first question, the 24 hour static culture 
studies indicate no significant difference in the percentage of 
proliferating cells in monlayers pretreated with NRBC and grown in 
DMEM as compared to the untreated controls. For monolayers 
pretreated with SRBC, however, there was a 30 percent decrease. 
These 24 hour data are shown in Figure 1, and similar results have 
been obtained for 72 hours of growth, where again there is no 
significant difference between NRBC treated monolayers versus 
untreated controls. 
To address the second question, flow experiments were 
conducted. In these untreated endothelial monolayers exposed to a 
30 dynes/cm2 steady flow of culture media exhibited a little change 
in cell proliferation. However, for monolayers which were SRBC 
treated, a 52 percent decrease in the percentage of proliferating 
cells was observed. Although somewhat less, there also was a 
decrease in cell proliferation for monolayers pretreated with 
NRBC. These results are shown in Figure 3-4. 
From these experiments it is clear that sickle ·erythrocyte 
interactions alter both .endothelial proliferation in static 
culture as well as the influence of flow on cell proliferation. 
Even though cell proliferation data indicate significant effects 
on endothelial cell function, it will be important to further 
explore this. Plans for this are discussed in Section 4. 
3. Significance 
The influence of the local hemodynamic environment on 
vascular endothelial biology is now well recognized. This 
includes both in vivo evidence as well as results from in vitro 
cell culture studies. The latter, which is by far the more 
extensive, indicate that the influence of hemodynamics extends to 
cell function and includes gene expression. 
In the studies conducted on this project we have found an 
alteration of the endothelial response to flow that is induced by 
sickle erythrocyte-endothelial interactions. This manifests 
itself not only in the elongation response, but also in the 
proliferation of endothelial cells. These findings suggest that 
the complex interaction between erythrocytes and endothelial 
cells, as modulated by the flow environment, may play an important 
role in vascular endothelial biology and in vascular pathobiologic 
complications associated with sickle cell disease. 
As will be discussed in the next section, our attention is 
now being directed into two different areas. One is a 
continuation of our work to date focusing on the mechanism(s) 
related to the effects we have observed. 
4. Plans 
For this coming year, we have two objectives. The first 
objective is to continue our search for the mechanism(s) involved 
in the inhibition of the EC elongation and alignment response 
which results from pretreatment of EC by SBRC. We plan to do this 
by investigating the dynamics of intracellular calcium which we 
believe is a key second messenger involved in the EC response to 
flow. When BAEC respond to flow by elongating and aligning, there 
is an elevation in intracellular calcium. However, when 
intracellular calcium is blocked, then there is an inhibition of 
EC elongation. 3 Since EC elongation is an active response to flow, 
one which involves the reorganization of the F-actin microfilarnent 
cytoskeletal structure, then quite possibly this is due to the 
role intracellular calcium has in regulating key actin-binding 
proteins. In order to investigate this, alterations in 
intracellular calcium in EC pretreated with SRBC will be measured 
using Fura-2 and a fluorescenced radiometric imaging technique. 4- 5 
These will be compared with the response of EC pretreated with 
NRBC as well as that of untreated EC. The critical question being 
asked is whether pretreatment with SRBC, as opposed to NRBC, 
alters intracellular calcium signaling in EC responding to flow. 
The second objective is to extend our studies to the gene 
expression level. Previous studies in our laboratory have 
provided a wide variety of evidence indicative of important 
effects of flow and the associated shear stress in the regulation 
of gene expression. Of parti~ular interest is nitric oxide (NO), 
a molecule which is a potent vasodilator and regulated by flow. 6- 7 
It also is linked to the nature of the vessel wall's oxidative 
environment. In cell culture studies of the acute response to the 
sudden onset of flow, there is a dramatic increase in NO release. 
There also is a chronic increase which appears to be the result of 
an upregulation in nitric oxide synthase (NOS), a catalyst in the 
conversion of L-arginine to NO. These studies will be extended to 
investigate how pretreatment of EC with SRBC influences the role 
of flow and the associated shear stress in the regulation of NO 
release and in particular NOS. In regard to this latter, NOS rnRNA 
will be measured both in EC pretreated by SRBC and NRBC and then 
exposed to flow and also in control, untreated EC. 
Other biologically active molecules which are candidates for 
our studies on the influence on EC of pretreatment with SRBC 
inc 1 ude CuI Zn SOD, PDGF, and MCP-1. In each case we have 
conducted previous studies demonstrating the important role of 
flow in the regulation of gene expression. 
We believe these planned studies will extend our knowledge of 
vascular endothelial biology. Equally well, this will contribute 
to a better understanding of the vascular complications which 
occur in patients with sickle cell disease. 
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5. Human Subjects 
a. General Guidelines 
i. Proposed Use 
Patients with sickle cell syndrome (HbSS, HbSC, HbS iS-
thalassemia) not receiving anticoagulant therapy and without 
evidence of pregnancy, obvious infection, thromboembolic disease 
or liver disease will be eligible for this study. Patients will 
be studied once in pain crisis and twice during asymptomatic 
periods. An age and sex matched population of normal black 
individuals will serve as a control population. Approximately 
twenty patients and twenty control subjects, aged eighteen or 
older, will be studied annually. Ten milliliters of blood will be 
drawn by venipuncture for each experiment. 
ii. Specimen Usage 
None of the data from the experiments will be used for 
diagnosis or treatment of specific individuals. 
iii. Patient Recruitment 
Patients from the Sickle Cell Center or the in-patient 
service at Grady Memorial Hospital, Atlanta, GA and hospital staff 
will be recruited by Dr. James R. Eckman. Subjects will agree to 
participate in this study by signing a consent form · approved by 
Georgia Tech and Emory School of Medicine IRBs. The consent form 
explains the nature of the study, the details of blood collection, 
risks associated with drawing blood, the availability of personnel 
to discuss the results of the study, the assurance of anonymity, 
and the ability to withdraw from _the study at any time without 
penalty or loss of benefits. 
iv. Potential Risks 
The risks of drawing blood are minimal and include slight 
pain, bruising, and infection at the site of the puncture. No 
viable alternative for drawing human blood exists. 
v. Procedures to Minimize Risk 
Patient confidentiality will be ensured by assigning a code 
to each patient studied (SSl, AAl for sickle and normal donor, 
respectively) to be used when all data is reported. Blood will be 
drawn at Grady Hospital under the supervision of Dr. James R. 
Eckman, director of the Sickle Cell Clinic. Dr. Eckman will be 
available to answer questions and to arrange for emergency medical 
care if a medical problem develops during the course of this 
study. 
vi. Justification 
The risk of drawing blood is minimal compared to potential 
benefits of a better understanding of clotting abnormalities in 
sickle cell syndromes and their relationship to pain crisis. 
b. Gender and Minority Inclusions 
Study subjects will be patients diagnosed with sickle cell 
syndromes as defined above. These patients will primarily be of 
African descent, however no patients will be included or excluded 
on the basis of race. The study population will consist of 
•approximately equal numbers of men and women. Exclusion criteria 
will be solely based on medical criteria as described above. 
Control subjects (volunteers without hemoglobinpathies) will be 
age, sex, and race-matched. These volunteers are recruited from 
the hospital staff at Grady Memorial Hospital in Atlanta. 
6. Vertebrate Animals 
None. 
7. Publications (from this project) 
a. Journal Articles 
Sherrill, A.W., Williams, J.J., Eckman, J.R., Wick, T.M., and 
Nerem, R.M., "Washed Sickle Cells Inhibit Arterial 
Endothelial Cell Elongation and Alignment in Response to 
Shear Stress,n ASME Journal of Biomechanical Engineering 
(submitted for publication) . 
Williams, J.J., Wick, T.M., and Nerem, R.M., "Short-Term Contact 
with Sickle Erythrocytes Inhibits Endothelial Cell 
Proliferative Activityn (in preparation). 
b. Abstracts and Meeting Presentations 
Sherrill, A.W., Williams, J., Wick, T.M., and Nerem, R.M., "Short-
Term Contact with Sickle Erythrocytes Inhibits Shear-Induced 
Elongation of Arterial Endothelium,n Annual Meeting of the 
American Society of Hematology, Nashville, TN, December 2-6, 
1994. 
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Omverslty of Oklahoma, Norman, OR B.S. 1959 Aeronautical Engr. 
The Ohio State University, Columbus, OH M.Sc. 1961 Aero-Astro. Engr. 
The Ohio State Universit , Columbus, OH Ph.D. 1964 Aero-Astro. En . 
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Assistant Professor, Dept. of Aeronautical and Astronautical Engineering, The Ohio State University, 
Columbus, OH 
Associate Professor, Dept. of Aeronautical and Astronautical Engineering, The Ohio State University, 
Columbus, OH 
Visiting Professor, Physiological Flow Studies Unit, Imperial College, London, England 
Professor, Dept. of Aeronautical and Astronautical Engineering, The Ohio State University and Professor, 
Dept. of Veterinary Physiology and Pharmacology (1975-1979) 
Associate Dean, Graduate School, The Ohio State University; primary responsibilities in area of research 
Professor and Chairman, Dept. of Mechanical Engineering, University of Houston, Houston, TX 
Visiting Professor, Institute of Biomedical Engineering, Swiss Federal Institute of Technology (ETH) and 
University of Zurich, Zurich, Switzerland 
Foundation Scientist, Southwest Foundation for Biomedical Research, San Antonio, TX 
Professor, Dept. of Pathology (Adjunct), The University of Texas Health Science Center at San Antonio, San 
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Visiting Professor, Bioengineering Division, Dept. of Applied Mechanics and Engineering Sciences, 
University of California, San Diego, CA 
Parker H. Petit Distinguished Chair for Engineering in Medicine, George W. Woodruff School of Mechanical 
Engineering, Georgia Institute of Technology, Atlanta, GA 
Institute Professor, Georgia Institute of Technology, Atlanta, GA 
Director, Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA 
Fellow, Council on Arteriosclerosis, American Heart Association, 1976 
Fellow, American Physical Society, 1982 
Fellow, American Society of Mechanical Engineers, 1984 
Konrad Witzig Memorial Lecture, Cardiovascular System Dynamics Society, 1986 
National Academy of Engineering, Elected 1988 
Senior Visiting Fellow, Japan Society for the Promotion of Science, 1989 
ASME Lissner Award, 1989 
Fellow, American Association for the Advancement of Science, 1990 
Honorary Doctorate (Docteur Honoris Causa), University of Paris, 1990 
Institute of Medicine, National Academy of Sciences, Elected 1992 
Foreign Member, Polish Academy of Sciences, Elected 1994 
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Current Support --
Source and identifying no. - National Institutes of Health Award for a Comprehensive 






"Comprehensive Sickle Cell Center" 
Director of Project 2 
1 0°/o 
Dates/costs entire project - 4/1/93 - 3/31/98; $460,831 
Dates/costs third year - 4/1/96 - 3/31/97; $124,333 
Specific aims of project - To study alteractions in vascular endothelial biology due to 
interactions with sickle red blood cells. 
Source and identifying no. - Whitaker Foundation 
P.l. - Robert M. Nerem 
Title - "Biomedical Engineering Development: Cellular Engineering at Emory and 
Georgia Tech" 
Role - Project Director 
0/o Effort - 2 0 °/o 
Dates/costs entire project - 9/1/93 - 8/31/98; $3,000,000 
Dates/costs third year - 9/1/99 - 8/31/97; $500,000 
Specific aims of project - To expand biomedical engineering program at Georgia Tech 
Scientific and budgetary overlap - None 
Source and identifying no. - National Science Foundation Grant BCS-941201 0 
P.l. - Robert M. Nerem 
Title -
Role-
"Tissue Engineering a Blood Vessel" 
P.l. 
0/o Effort - 2 0 °/o 
Dates/costs entire project - 9/1/94 - 2/28/97; $341,014 
Dates/costs current year- 9/1/95- 8/31/96; $173,613 
Specific aims of project - To develop a tissue-engineered blood vessel substitute. 
Scientific and budgetary overlap - None 






Robert M. Nerem 
"Cellular Engineering" 
P.l. 
Dates/costs entire project - 9/26/91 - 6/30/01; $814,183 
Dates/costs current year - 7/1/96 - 6/30/97; $79,163 
Specific aims of project - To train pre-doctoral students in cellular engineering. 
Scientific and budgetary overlap - None 
Source and identifying no. - National Institutes of Health Grant No. 1 P01 HL48667-




R. Wayne Alexander 
"Initiating Events in Vascular Lesion Formation" 
Collaborator on Project 2 
0/o Effort - 1 0 °/o 
Dates/costs entire project - 9/30/92 - 9/29/97; $1 ,274,908 
Dates/costs current year - 9/30/95 - 9/29/96; $59,135 
Specific aims of project - To study the role of shear stress in regulation by the oxidative 
environment of the oxidative adhesion molecule expression and monocyte adherence. 
Scientific and budgetary overlap - None 
Source and identifying no. - National Institutes of Health Grant HL52218 
(Subcontract from University of Texas Health Science Center at San Antonio) 
P .I. - E.A. Sprague 
Title - "Flow Regulation of Monocyte-Endothelial Interaction" 
Role - ~a-Investigator 
0/o Effort - 1 0 °/o 
Dates/costs entire project - 5/1/95 - 4/30/00; $520,795 
Dates/costs first year - 5/1/96 - 4/30/97; $101,281 
Specific aims of project - To investigate the flow regulation of monocyte-endothelial 
adherence. 
Scientific and budgetary overlap - None 
Source and Identifying no. - NASA NAG 9-836 (subcontract from MIT) 
P.l. - lisa E. Freed 
Title - "Microgravity Tissue Engineering" 
Role - Co-Investigator and Director, Georgia Tech Effort 
0/o Effort -
Dates/costs entire project - 7/1/95 - 6/30/99; $1,284,445 
Dates/costs current year - 9/1/95 - 8/31/96; $293,227 
Specific aims of project - To study the influence of fluid forces on the tissue engineering of 3-D 
constructs. 
Scientific and budgetary overlap - None 

